Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02144701
What this trial is testing

Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
Rutgers, The State University of New Jersey 33
Large-scale testing (Phase 3)Not Yet RecruitingNCT07588945
What this trial is testing

DaGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 438
Not applicableUnknownNCT05992272
What this trial is testing

Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer

Who this might be right for
Alcohol Use Disorder (AUD)AlcoholismSubstance Use Disorders+3 more
Charite University, Berlin, Germany 300
Testing effectiveness (Phase 2)Looking for participantsNCT07325253
What this trial is testing

A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations

Who this might be right for
Pilot StudyPET/CT ImagingHost Disease Manifestation
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT01175148
What this trial is testing

Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

Who this might be right for
Graft vs Host Disease
West Virginia University 60
Testing effectiveness (Phase 2)WithdrawnNCT00081055
What this trial is testing

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Mesoblast International Sàrl
Testing effectiveness (Phase 2)Study completedNCT04397367
What this trial is testing

Low Dose Ruxolitinib in Combination With Methylprednisolone

Who this might be right for
aGVHDStem Cell Transplant Complications
Chinese PLA General Hospital 38
Early research (Phase 1)Study completedNCT00062621
What this trial is testing

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Who this might be right for
Kidney Failure, ChronicMultiple Myeloma
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Ended earlyNCT02488304
What this trial is testing

Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)

Who this might be right for
Bronchiolitis ObliteransLung Transplant Rejection
FLUIDDA nv 10
Not applicableStudy completedNCT01369914
What this trial is testing

The Natural History of Graft-Versus-Host Disease in the Eyes

Who this might be right for
Graft-Versus-Host Disease
National Eye Institute (NEI) 61
Not applicableStudy completedNCT01866332
What this trial is testing

Effectiveness of the Addition of the Kinesio Taping Method to Conventional Physical Therapy Treatment in Patients With Chronic Nonspecific Low Back Pain

Who this might be right for
Nonspecific Chronic Low Back Pain
Universidade Cidade de Sao Paulo 148
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Post-approval studies (Phase 4)Ended earlyNCT01820078
What this trial is testing

Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)

Who this might be right for
Chronic Kidney Disease, Unspecified
Fundación Renal Iñigo Alvarez De Toledo 127
Not applicableEnded earlyNCT03438643
What this trial is testing

Dynamic of Immunocompetent Populations in Patients Treated With Extracorporeal Photopheresis in Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host DiseaseExtracorporeal Photopheresis
University Hospital, Lille 8
Large-scale testing (Phase 3)Ended earlyNCT04039347
What this trial is testing

Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)

Who this might be right for
Bronchiolitis ObliteransObliterative BronchiolitisBronchiolitis Obliterans Syndrome
Zambon SpA 164
Not applicableUnknownNCT03146793
What this trial is testing

The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort

Who this might be right for
CalciphylaxisRenal Insufficiency, Chronic
Centre Hospitalier St Esprit 600
Testing effectiveness (Phase 2)Study completedNCT00328198
What this trial is testing

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Genzyme, a Sanofi Company 86
Not applicableStudy completedNCT00829348
What this trial is testing

Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins

Who this might be right for
Dyslipidemia
Hillel Yaffe Medical Center 120
Not applicableStudy completedNCT06240078
What this trial is testing

Impact of COPD on Sexual Health, Loneliness, and Well-being

Who this might be right for
Pulmonary Disease, Chronic ObstructiveSexual HealthLoneliness+1 more
Vejle Hospital 521
Testing effectiveness (Phase 2)Study completedNCT01523821
What this trial is testing

Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)

Who this might be right for
Graft-Versus-Host Disease (GVHD) Acute on Chronic
Fred Hutchinson Cancer Center 20
Next Page